UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: . | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 243.

.

., MS; ., MF; ., AP; ., PG; ., MJR; ., FY; ., AS; ... ., NM; + view all (2008) High Resolution Allotyping of Four Alleles of HLA-DRB1*01 Group in Iranians Using Reverse-SSOPH Assay in Comparison with DNA Sequencing and PCR-SSP. Journal of Biological Sciences , 8 (2) pp. 392-397. 10.3923/jbs.2008.392.397.

A

Austin, SK; Starke, RD; Lawrie, AS; Cohen, H; Machin, SJ; Mackie, IJ; (2008) The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction. BRIT J HAEMATOL , 141 (4) 536 - 544. 10.1111/j.1365-2141.2008.07074.x.

B

Baker, RJ; Holmes, AM; Reed, MC; Mehta, AB; Hughes, DA; (2008) Denaturing high-performance liquid chromatography: an effective way of screening for Fabry disease? Presented at: UNSPECIFIED.

Bartoli, M; Gicquel, E; Barrault, L; Soheili, T; Malissen, M; Malissen, B; Vincent-Lacaze, N; ... Richard, I; + view all (2008) Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation. Hum Mol Genet , 17 (9) pp. 1214-1221. 10.1093/hmg/ddn029.

Berro, M; Cooke, L; Mayor, NP; Kusminsky, G; Marsh, SGE; Madrigal, JA; Shaw, BE; (2008) TGFB1 Functional Polymorphisms: Impact on Outcome in Allogeneic Unrelated Donor Haematopoietic Stem Cell Transplantation. In: BLOOD. (pp. 1036 - 1036). AMER SOC HEMATOLOGY

Bjorkqvist, M; Wild, EJ; Thiele, J; Silvestroni, A; Andre, R; Lahiri, N; Raibon, E; ... Tabrizi, SJ; + view all (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. Journal of Experimental Medicine , 205 (8) 1869 - 1877. 10.1084/jem.20080178. Green open access
file

Bloor, AJ; Thomson, KJ; Chowdhry, N; Verfuerth, S; Ings, SJ; Chakraverty, R; Linch, DC; ... Mackinnon, S; + view all (2008) High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma. Biol Blood Marrow Transplant , 14 (1) pp. 50-58.

Bloor, AJC; Thomson, K; Chowdhry, N; Verfuerth, S; Ings, SJ; Chakraverty, R; Linch, DC; ... Mackinnon, S; + view all (2008) High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma. BIOL BLOOD MARROW TR , 14 (1) 50 - 58. 10.1016/j.bbmt.2007.04.013.

Brewin, J; Straathof, K; Karlsson, H; Mancao, C; Savoldo, B; Dotti, G; Pule, M; (2008) A Novel Strategy to Render CTL Resistant to Immunosuppression with Calcineurin Inhibitors. In: (Proceedings) 50th Annual Meeting of the American-Society-of-Hematology. (pp. p. 1328). AMER SOC HEMATOLOGY

Briesemeister, D; Listopad, J; Kammertons, T; Blankenstein, T; (2008) Little effect of local IFN gamma on established tumors. WIEN KLIN WOCHENSCHR , 120 95 - 95.

Briggs, C; Guthrie, D; Hyde, K; Mackie, I; Parker, N; Popek, M; Porter, N; (2008) Guidelines for point-of-care testing: haematology. BRIT J HAEMATOL , 142 (6) 904 - 915. 10.1111/j.1365-2141.2008.07274.x.

Buch, PK; McIntosh, J; Georgiadis, A; Mowat, F; Tschernutter, M; Smith, AJ; Nathwani, AC; (2008) Pseudotyped adeno-associated viral vectors to enhance gene replacement therapy in a mouse model of retinal degeneration. In: HUMAN GENE THERAPY. (pp. 410 - 410). MARY ANN LIEBERT INC

Buckley, SM; Howe, SJ; Wong, SP; Buning, H; McIntosh, J; Baker, A; Nathwani, AC; ... Waddington, S; + view all (2008) Luciferin detection after intra-nasal vector delivery is improved by intra-nasal rather than intra-peritoneal luciferin administration. Hum Gene Ther 10.1089/hgt.2008.023.

Buckley, SM; Howe, SJ; Wong, SP; Buning, H; McIntosh, J; Baker, A; Nathwani, AC; ... Waddington, S; + view all (2008) Luciferin detection after intra-nasal vector delivery is improved by intra-nasal rather than intra-peritoneal luciferin administration. Hum Gene Ther 10.1089/hgt.2008.023.

Buckley, SMK; Howe, SJ; Rahim, AA; Buning, H; McIntosh, J; Wong, SP; Baker, AH; ... Waddington, SN; + view all (2008) Luciferin Detection After Intranasal Vector Delivery Is Improved by Intranasal Rather Than Intraperitoneal Luciferin Administration. HUM GENE THER , 19 (10) 1050 - 1056. 10.1089/hum.2008.023.

Buj-Bello, A; Fougerousse, F; Schwab, Y; Messaddeq, N; Spehner, D; Pierson, CR; Durand, M; ... Mandel, J-L; + view all (2008) AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. Hum Mol Genet , 17 (14) pp. 2132-2143. 10.1093/hmg/ddn112.

C

Calvaruso, V; Maimone, S; Gatt, A; Tuddenham, E; Thursz, M; Pinzani, M; Burroughs, AK; (2008) Coagulation and fibrosis in chronic liver disease. GUT , 57 (12) pp. 1722-1727. 10.1136/gut.2008.150748.

Camilleri, RS; Cohen, H; Mackie, IJ; Scully, M; Starke, RD; Crawley, JTB; Lane, DA; (2008) Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura. J THROMB HAEMOST , 6 (2) 331 - 338.

Cappellin, MD; Elalfy, MS; Kattamis, A; Seymour, JF; Lee, CL; Porter, JB; El-Beshlawy, A; ... Taber, A; + view all (2008) Efficacy and Safety of Once-Daily, Oral Iron Chelator Deferasirox (Exjade (R)) in a Large Group of Regularly Transfused Patients with beta-Thalassemia Major. In: BLOOD. (pp. 1321 - 1321). AMER SOC HEMATOLOGY

Cappellini, MD; Gattermann, N; Viprakasit, V; Lee, JW; Porter, JB; El-Beshlawy, A; Kattamis, A; ... Elalfy, MS; + view all (2008) Transfusion History, Iron Chelation Practices and Status of Iron Overload across Various Transfusion-Dependent Anemias: Data from the Large-Scale, Prospective, 1-Year EPIC Trial. In: BLOOD. (pp. 1321 - 1322). AMER SOC HEMATOLOGY

Cappellini, MD; Taher, A; Vichinsky, E; Galanello, R; Piga, A; Lawniczek, T; Jehl, V; ... Porter, JB; + view all (2008) EFFICACY AND TOLERABILITY OF DEFERASIROX DOSES > 30 MG/KG/DAY IN PATIENTS WITH TRANSFUSION-DEPEN DENT ANAEMIA AND IRON OVERLOAD. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 336 - 336). FERRATA STORTI FOUNDATION Gold open access

Carlisle, RC; Benjamin, R; Briggs, SS; Sumner-Jones, S; McIntosh, J; Gill, D; Hyde, S; ... Fisher, KD; + view all (2008) Coating of adeno-associated virus with reactive polymers can ablate virus tropsim, enable retargeting and provide resistance to neutralising antisera. J GENE MED , 10 (4) 400 - 411. 10.1002/jgm.1161.

Chakraverty, R; Flutter, B; Fallah-Arani, F; Eom, HS; Means, T; Andreola, G; Schwarte, S; ... Sykes, M; + view all (2008) The Host Environment Regulates the Function of CD8(+) Graft-versus-Host-Reactive Effector Cells. J IMMUNOL , 181 (10) 6820 - 6828.

Chappert, P; Leboeuf, M; Rameau, P; Stockholm, D; Liblau, R; Danos, O; Davoust, JM; (2008) Antigen-driven interactions with dendritic cells and expansion of Foxp3+ regulatory T cells occur in the absence of inflammatory signals. J Immunol , 180 (1) pp. 327-334. 10.4049/jimmunol.180.1.327.

Clarke, J; Beck, M; Giugliani, R; Sunder-Plassmann, G; Linhart, A; Hernberg-Stahl, E; Mehta, A; (2008) The Fabry Outcome Survey (FOS): A database of prospective observations on the natural history and management of a rare disease. Value in Health , 11 (3)

Cohen, AR; Glimm, E; Porter, JB; (2008) Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. BLOOD , 111 (2) 583 - 587. 10.1182/blood-2007-08-109306.

Cohen, H; (2008) Antiphospholipid syndrome: clinical presentations and diagnosis. [Lecture]. Presented at: Key advances in antiphospholipid syndrome, Royal Society of Medicine, london.

Cohen, H; (2008) SHOT data 2007 Part 1. [Lecture]. Presented at: SHOT annual symposium, Royal Society of Medicine, London.

Cotton, RGH; Auerbach, AD; Beckmann, JS; Blumenfeld, OO; Brookes, AJ; Brown, AF; Carrera, P; ... den Dunnen, JT; + view all (2008) Recommendations for locus-speciific databases and their curation. HUMAN MUTATION , 29 (1) pp. 2-5. 10.1002/humu.20650.

Crawley, JTB; Efthymiou, M; (2008) Cytoprotective effect of activated protein C: specificity of PAR-1 signaling. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 6 (6) pp. 951-953. 10.1111/j.1538-7836.2008.02951.x.

D

Danos, O; (2008) AAV vectors for RNA-based modulation of gene expression. Gene Ther , 15 (11) pp. 864-869. 10.1038/gt.2008.69.

David, AL; McIntosh, J; Nathwani, A; Cook, T; Boyd, M; Weisz, B; Wigley, V; ... Peebles, DM; + view all (2008) Long-term expression of human factor IX after ultrasound-guided delivery of AAV8 hFIX to fetal sheep in utero. Presented at: UNSPECIFIED.

David, AL; McIntosh, J; Nathwani, A; Cook, T; Boyd, M; Weisz, B; Wigley, V; ... Peebles, D; + view all (2008) Long term expression of human factor IX after ultrasound-guided fetal gene therapy in sheep. In: REPRODUCTIVE SCIENCES. (pp. 134A - 134A). SAGE PUBLICATIONS INC

David, AL; McIntosh, J; Weisz, B; Boyd, M; Cook, T; Wigley, V; Kymalainen, H; ... Nathwani, A; + view all (2008) Long term perinatal gene transfer after clinically applicable delivery of prenatal gene therapy in the sheep. Presented at: 5th Annual Conference of the British-Society-for-Gene-Therapy, Edinburgh, SCOTLAND.

Davies, FE; Wu, P; Boyd, K; Saso, R; Potter, MN; Ethell, ME; Shaw, BE; ... Morgan, GJ; + view all (2008) Autologous Transplantation Is the Optimum Approach to the Management of Myeloma Patients with Extramedullary Disease at Presentation. In: BLOOD. (pp. 1137 - 1138). AMER SOC HEMATOLOGY

Deegan, PB; Tindall, JE; Stein, PE; Mehta, A; Hughes, DA; Wraith, JE; Waldek, S; (2008) OSSEOUS COMPLICATIONS OF GAUCHER DISEASE: A NATIONAL SURVEY. Presented at: 5th Symposium on Lysosomal Storage Disorders, Paris, FRANCE.

Delgado, J; Pillai, S; Benjamin, R; Caballero, D; Martino, R; Nathwani, A; Lovell, R; ... Mackinnon, S; + view all (2008) The Effect of In Vivo T Cell Depletion with Alemtuzumab on Reduced-intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia. BIOL BLOOD MARROW TR , 14 (11) 1288 - 1297. 10.1016/j.bbmt.2008.09.001.

Della Peruta, M; Martinelli, M; Monne, M; Pintani, D; Grafone, T; Iacobucci, I; Murineddu, M; ... Sorio, C; + view all (2008) DOWN-REGULATION OF PROTEIN TYROSINE PHOSPHATASE gamma (PTPRG) IN CHRONIC MYELOID LEUKEMIA (CML). In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 42 - 42). FERRATA STORTI FOUNDATION Gold open access

Delluc-Clavières, A; Le Bec, C; Van den Berghe, L; Conte, C; Allo, V; Danos, O; Prats, A-C; (2008) Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES. Gene Ther , 15 (15) pp. 1090-1098. 10.1038/gt.2008.49.

Dignan, FL; Evans, SO; Ethell, ME; Shaw, BE; Riley, UBG; Davies, F; Treleaven, JG; ... Potter, MN; + view all (2008) An Early CT-Diagnosis Based Treatment Strategy for Invasive Fungal Infection in Allogeneic Transplant Recipients Using Caspofungin First Line: An Effective Strategy with Low Mortality. In: BLOOD. (pp. 420 - 420). AMER SOC HEMATOLOGY

Dunn, N; Miller, R; Griffioen, A; (2008) How does being a carrier affect women and their partners: experience in the UK. HAEMOPHILIA , 14 129 - 129.

Dunn, NF; Miller, R; Griffioen, A; Lee, CA; (2008) Carrier testing in haemophilia A and B: adult carriers' and their partners' experiences and their views on the testing of young females. HAEMOPHILIA , 14 (3) 584 - 592. 10.1111/j.1365-2516.2007.01649.x.

de Groot, NG; Otting, N; Robinson, J; Marsh, SGE; Bontrop, RE; (2008) The IPD-MHC-NHP database: the primary source of MHC data for non-human primate sequences. In: (Proceedings) 22nd European Immunogenetics and Histocompatibility Conference. (pp. p. 349). BLACKWELL PUBLISHING

E

Ehsanullah, J; Lambrianides, A; Mackie, I; Chen, P; Latchman, D; Isenberg, D; Rahman, A; (2008) Sequence motifs in a human monoclonal Antiphospholipid antibody determine its ability to bind and affect the function of serine proteases. In: ARTHRITIS AND RHEUMATISM. (pp. S403 - S404). WILEY-LISS

Evans, A; Riva, A; Cooksley, H; Phillips, S; Nathwani, A; Craigen, J; Brett, S; ... Naoumov, N; + view all (2008) Longitudinal analysis of PD1 expression: Impact of HBeAg seroconversion during antiviral treatment of chronic hepatitis B. In: JOURNAL OF HEPATOLOGY. (pp. S31 - S31). ELSEVIER SCIENCE BV

Evans, A; Riva, A; Cooksley, H; Phillips, S; Puranik, S; Nathwani, A; Brett, S; ... Naoumov, NV; + view all (2008) Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion. HEPATOLOGY , 48 (3) 759 - 769. 10.1002/hep.22419.

Evans, RW; Rafique, R; Zarea, A; Rapisarda, C; Cammack, R; Evans, PJ; Porter, JB; (2008) Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera. J BIOL INORG CHEM , 13 (1) 57 - 74. 10.1007/s00775-007-0297-8.

Everington, T.F.; (2008) Investigation of the molecular & functional pathophysiology of Polycythaemia Vera. pp. 1-225. Green open access
file

F

Fielding, AK; (2008) The treatment of adults with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program pp. 381-389. 10.1182/asheducation-2008.1.381. Gold open access

Fielding, AK; (2008) Viral therapy of cancer; measles virus. In: Harrington, KJ and Vile, RG and Pandha, HS, (eds.) Viral therapy of cancer. Wiley

Fielding, AK; Goldstone, AH; (2008) Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia. BONE MARROW TRANSPL , 41 (5) 447 - 453. 10.1038/sj.bmt.1705904.

Fiore, MM; Mackie, IJ; (2008) Dual Effect of Platelet Factor Four on the Activities of Factor Xa. In: BLOOD. (pp. 379 - 379). AMER SOC HEMATOLOGY

Fiore, MM; Mackie, IJ; (2008) Molecular weight-Dependent Mechanism of Heparin Neutralization by Platelet factor 4. In: BLOOD. (pp. 703 - 704). AMER SOC HEMATOLOGY

Flutter, BR; Fallah-Arani, F; Bennett, C; Sivakumaran, J; Freeman, GJ; Sykes, M; Chakraverty, R; (2008) Peripheral Alloantigen Drives Early Dysfunction and Eventual Exhaustion of CTL Following Delayed Donor Leukocyte Infusions. In: BLOOD. (pp. 817 - 817). AMER SOC HEMATOLOGY

Foley, JH; Kim, P; Nesheim, ME; (2008) Thrombin-activable Fibrinolysis Inhibitor Zymogen Does Not Play a Significant Role in the Attenuation of Fibrinolysis. Journal of Biological Chemistry , 283 (14) pp. 8863-8867. 10.1074/jbc.m800127200.

Fung, EB; Harmatz, PR; Milet, M; Balasa, V; Ballas, SK; Casella, JE; Hilliard, L; ... Multi Ctr Iron Oveload Res Grp, ; + view all (2008) Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions. TRANSFUSION , 48 (9) 1971 - 1980. 10.1111/j.1537-2995.2008.01775.x.

G

Gale, DP; Harten, SK; Reid, CDL; Tuddenham, EGD; Maxwell, PH; (2008) Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2 alpha mutation. BLOOD , 112 (3) 919 - 921.

Gale, R; Hills, R; Green, C; Patel, Y; Gilkes, A; Lazenby, M; Wheatley, K; ... Burnett, A; + view all (2008) The Impact of FLT3-ITD and NPM1 Mutational Status on the Outcome of ATRA Therapy in Patients with Non-APL AML: Results of the UK MRC AML12 Trial. In: BLOOD. (pp. 207 - 207). AMER SOC HEMATOLOGY

Gale, RE; Green, C; Allen, C; Mead, AJ; Burnett, AK; Hils, RK; Linch, DC; (2008) The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. BLOOD , 111 (5) 2776 - 2784. 10.1182/blood-2007-08-109090.

Garbowski, M; Eleftheriou, P; Pennell, D; Tanner, M; Porter, JB; (2008) Impact of Compliance, Ferritin and LIC on Long-Term Trends in Myocardial T2*with Deferasirox. In: BLOOD. (pp. 49 - 50). AMER SOC HEMATOLOGY

Gardiner, C; (2008) The SmartCheck INR system. AMERICAN JOURNAL OF CLINICAL PATHOLOGY , 129 (5) p. 826.

Gardiner, C; Adcock, DM; Carrington, LR; Kottke Marchant, K; Marlar, RA; McGlasson, DL; Fisher Trumbull, K; ... Daniele, C; + view all (2008) Protocol for the Evaluation, Validation, and Implementation of Coagulometers; Approved Guideline H57-A. Clinical and Laboratory Standards Institute

Gardiner, C; Longair, I; Hills, J; Cohen, H; Mackie, IJ; Machin, SJ; (2008) Performance evaluation of a new small-volume coagulation monitor - The SmartCheck INR system. AM J CLIN PATHOL , 129 (3) 500 - 504. 10.1309/K87FWL7UA8H8ANHR.

Gardiner, C; Longair, I; Hills, J; Pescott, M; Machin, S; Cohen, H; (2008) Patient self-monitoring of INR in the antiphospholipid syndrome. In: (pp. p. 137). WILEY-BLACKWELL

Gardiner, C; Longair, I; Pescott, M; Erwin, H; Hills, J; Machin, S; Cohen, H; (2008) Self-monitoring of oral anticoagulation: does it work in the real world? In: (pp. p. 49). WILEY-BLACKWELL

Gardiner, C; Machin, SJ; Mackie, IJ; (2008) Measuring thrombin generation based sensitivity to activated protein C using an automated coagulometer (ACL 9000). INT J LAB HEMATOL , 30 (4) 261 - 268. 10.1111/j.1751-553X.2007.00944.x.

Gardiner, C.; (2008) Antiphospholipid antibodies and the protein C pathway. Doctoral thesis , University of London. Green open access
file

GeurtsvanKessel, CH; Willart, MAM; van Rijt, LS; Muskens, F; Kool, M; Baas, C; Thielemans, K; ... Lambrecht, BN; + view all (2008) Clearance of influenza virus from the lung depends on migratory langerin(+)CD11b(-) but not plasmacytoid dendritic cells. JOURNAL OF EXPERIMENTAL MEDICINE , 205 (7) pp. 1621-1634. 10.1084/jem.20071365.

Gilleece, MH; Pearce, R; Linch, DC; Wilson, M; Towlson, K; Mackinnon, S; Potter, M; ... Marks, DI; + view all (2008) The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study. HEMATOLOGY , 13 (2) 119 - 127. 10.1179/102453308X315915.

Glasow, A; Barrett, A; Petrie, K; Gupta, R; Boix-Chornet, M; Zhou, D-C; Grimwade, D; ... Zelent, A; + view all (2008) DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia. BLOOD , 111 (4) pp. 2374-2377. 10.1182/blood-2007-05-088344.

Glasow, A; Barrett, A; Petrie, K; Gupta, R; Boix-Chornet, M; Zhou, DC; Grimwade, D; ... Zelent, A; + view all (2008) DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia. Blood , 111 (4) pp. 2374-2377.

Glasow, A; Barrett, A; Petrie, K; Gupta, R; Boix-Chornet, M; Zhou, DC; Grimwade, D; ... Zelent, A; + view all (2008) DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia. Blood , 111 (4) 2374 - 2377.

Goldstone, AH; Richards, SM; Fielding, AK; Rowe, JM; (2008) Chemotherapy or allografting for young adults with high-risk ALL? Response. BLOOD , 111 (12) 5755 - 5755.

Goldstone, AH; Richards, SM; Lazarus, HM; Tallman, MS; Buck, G; Fielding, AK; Burnett, AK; ... Rowe, JM; + view all (2008) In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). BLOOD , 111 (4) 1827 - 1833. 10.1182/blood-2007-10-116582.

Gonnet, F; Bouazza, B; Millot, GA; Ziaei, S; Garcia, L; Butler-Browne, GS; Mouly, V; ... Svinartchouk, F; + view all (2008) Proteome analysis of differentiating human myoblasts by dialysis-assisted two-dimensional gel electrophoresis (DAGE). Proteomics , 8 (2) pp. 264-278. 10.1002/pmic.200700261.

Goold, H; Escors, D; Chakraverty, R; Bennett, CL; (2008) Investigation of the requirement for skin DC in the activation of lentiviral vaccination responses. In: IMMUNOLOGY. (pp. 53 - 53). WILEY-BLACKWELL PUBLISHING, INC

Graham, T; McIntosh, J; Work, LM; Nathwani, A; Baker, AH; (2008) Performance of AAV8 vectors expressing human factor IX from a hepatic-selective promoter following intravenous injection into rats. Genet Vaccines Ther , 6 9-. 10.1186/1479-0556-6-9. Gold open access

Green, C; Linch, DC; Gale, RE; (2008) Most acute myeloid leukaemia patients with intermediate mutant FLT3/ITD levels do not have detectable bi-allelic disease, indicating that heterozygous disease alone is associated with an adverse outcome. BRIT J HAEMATOL , 142 (3) 423 - 426. 10.1111/j.1365-2141.2008.07196.x.

Gupta, M; Raghavan, M; Gale, RE; Chelala, C; Allen, C; Molloy, G; Chaplin, T; ... Young, BD; + view all (2008) Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia. GENE CHROMOSOME CANC , 47 (9) 729 - 739. 10.1002/gcc.20573.

Guy, C; Gilkes, A; Gale, R; Linch, DC; Hills, R; Burnett, AK; (2008) The Impact of MN1 Over-Expression on the Outcome of Younger Patients with AML Treated with Intensive Chemotherapy with or without ATRA Therapy. In: BLOOD. (pp. 1023 - 1023). AMER SOC HEMATOLOGY

H

Harmatz, P; Jonas, MM; Kwiatkowski, JL; Wright, EC; Fischer, R; Vichinsky, E; Giardina, PJ; ... Thalassemia Clinical Res Network, ; + view all (2008) Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. HAEMATOL-HEMATOL J , 93 (8) 1247 - 1251. 10.3324/haematol.12352. Gold open access

Holmes, AM; Reed, M; Baker, RJ; Papa, I; Mchta, AB; Hughes, DA; (2008) Expression of CD11b by monocytes and clinical phenotype in Fabry disease. Presented at: UNSPECIFIED.

Hong, DL; Gupta, R; Ancliff, P; Atzberger, A; Brown, J; Soneji, S; Green, J; ... Enver, T; + view all (2008) Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. SCIENCE , 319 (5861) 336 - 339. 10.1126/science.1150648.

Howe, SJ; Mansour, M; Brugman, M; Pike-Overzet, K; Hubank, M; Jina, N; de Ridder, D; ... Thrasher, AJ; + view all (2008) Molecular analysis of a severe adverse event in the UKSCID-X1 gene therapy clinical trial. In: HUMAN GENE THERAPY. (pp. 421 - 421). MARY ANN LIEBERT INC

Howe, SJ; Mansour, MR; Schwarzwaelder, K; Bartholomae, C; Hubank, M; Kempski, H; Brugman, MH; ... Thrasher, AJ; + view all (2008) Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. Journal of Clinical Investigation , 118 (9) pp. 3143-3150. 10.1172/JCI35798.

Howe, SJ; Mansour, MR; Schwarzwaelder, K; Bartholomae, C; Hubank, M; Kempski, H; Brugman, MH; ... Thrasher, AJ; + view all (2008) Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J CLIN INVEST , 118 (9) 3143 - 3150. 10.1172/JCI35798. Gold open access

Hughes, D; Ginsberg, L; Baker, R; Goodwin, S; (2008) Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: a case report of 24 months' oral substrate reduction therapy with miglustat. PARKINSONISM & RELATED DISORDERS , 14 (1) p. 83. 10.1016/j.parkreldis.2007.01.001.

Hughes, D; Ginsberg, L; Baker, R; Goodwin S, M; A, R; L, M; A, ; (2008) Reply: Effective treatment of an elderly patient with Gaucher’s disease and Parkinsonism: a case report of 24 months’ oral substrate reduction therapy with miglustat. Parkinsonism and Related Disorders , 14 (1) 83 - 83. 10.1016/j.parkreldis.2007.01.001.

Hughes, DA; (2008) Early therapeutic intervention in females with Fabry disease? Acta Paediatr , 97 (457) pp. 41-47. 10.1111/j.1651-2227.2008.00649.x.

Hughes, DA; (2008) Early therapeutic intervention in females with Fabry disease? In: ACTA PAEDIATRICA. (pp. 41 - 47). BLACKWELL PUBLISHING

Hughes, DA; Deegan, PB; Milligan, A; Bruce, R; Goodwin, S; Richfield, L; Mehta, AB; (2008) Enzyme replacement therapy with agalsidase alfa in patients with Fabry disease: the effects of altered infusion interval and increased dose. Presented at: UNSPECIFIED.

Hughes, DA; Elliott, PM; Shah, J; Zuckerman, J; Coghlan, G; Brookes, J; Mehta, AB; (2008) Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: A randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart , 94 (2) pp. 153-158. 10.1136/hrt.2006.104026.

Hughes, DA; Elliott, PM; Shah, J; Zuckerman, J; Coghlan, G; Brookes, J; Mehta, AB; (2008) Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. HEART , 94 (2) 153 - 158. 10.1136/hrt.2006.104026.

Hughes, DA; Milligan, A; Mehta, A; (2008) Home therapy for lysosomal storage disorders. British Journal of Nursing , 16 (22) pp. 1384-1389.

Hughes, DS; Norwood, F; Sawicka, E; Milligan, A; Pringle, S; Bruce, R; Goodwin, S; ... Mehta, AB; + view all (2008) Initial therapeutic response to enzyme replacement therapy with Myozyme (R) in a sibling cohort with late-onset Pompe disease. Presented at: 2nd European Symposium on Steps Forward in Pompe Disease, Nice, FRANCE.

I

Ingram, W; Devereux, S; Das-Gupta, EP; Russell, NH; Haynes, AP; Byrne, JL; Shaw, BE; ... Pagliuca, A; + view all (2008) Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma. BRIT J HAEMATOL , 141 (2) 235 - 243. 10.1111/j.1365-2141.2008.07067.x.

J

James, KMH; Melikian, CN; Chowdary, P; Mallett, SV; (2008) Thromboelastography-guided recombinant factor VIIa administration in a patient with refractory autoimmune idiopathic thrombocytopenia. ANESTHESIA AND ANALGESIA , 107 (2) pp. 402-405. 10.1213/ane.0b013e3181770b87.

K

Kim, PYG; Foley, J; Hsu, G; Kim, PY; Nesheim, ME; (2008) An assay for measuring functional activated thrombin-activatable fibrinolysis inhibitor in plasma. Analytical Biochemistry , 372 (1) pp. 32-40. 10.1016/j.ab.2007.09.034.

Koehn, BH; Ford, ML; Ferrer, IR; Borom, K; Gangappa, S; Kirk, AD; Larsen, CP; (2008) PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue. J Immunol , 181 (8) pp. 5313-5322. 10.4049/jimmunol.181.8.5313.

Kogelberg, H; Tolner, B; Thomas, GJ; Di Cara, D; Minogue, S; Ramesh, B; Sodha, S; ... Chester, K; + view all (2008) Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus. JOURNAL OF MOLECULAR BIOLOGY , 382 (2) pp. 385-401. 10.1016/j.jmb.2008.07.013.

Kottaridis, P; North, J; Bakhsh, I; Samuel, E; Mackinnon, S; Lowdell, MW; (2008) A Phase I/II Clinical Trial of Tumour-Activated Allogeneic Natural Killer Cells in AML. In: BLOOD. (pp. 998 - 998). AMER SOC HEMATOLOGY

Kottaridis, P; Thomson, K; Cassoni, A; Pearce, R; Chakraverty, R; Morris, E; Peggs, K; (2008) Myeloablative allogeneic stem cell transplantation with unrelated donors for high-risk acute myeloid leukaemia: no increase in relapse with alemtuzumab-depleted grafts. In: BONE MARROW TRANSPLANTATION. (pp. S73 - S73). NATURE PUBLISHING GROUP

Kottaridis, PD; Thomson, K; Fielding, AK; Morris, E; Chakraverty, R; Peggs, K; Mackinnon, S; (2008) Successful salvage of high risk/relapsed AML with T-cell depleted allogeneic transplant: comparable outcome to standard risk disease even with the use of unrelated donors. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 57 - 57). BLACKWELL PUBLISHING

Kounas, S; Demetrescu, C; Pantazis, AA; Keren, A; Lee, PJ; Hughes, D; Mehta, A; (2008) The binary endocardial appearance is a poor discriminator of Anderson-Fabry disease from familial hypertrophic cardiomyopathy. J AM COLL CARDIOL , 51 (21) 2058 - 2061. 10.1016/j.jacc.2008.02.046.

Krishnamurty, S; Shaw, BE; Byrne, JL; Seedhouse, C; Mayor, NP; Madrigal, AJ; Russell, NH; (2008) The Effect of the CASP8-6526N Del Promoter Polymorphism on Outcome in T-Cell Depleted Unrelated Donor Haemopoetic Stem Cell Transplants (HSCT). In: BLOOD. (pp. 1032 - 1032). AMER SOC HEMATOLOGY

Kyriakou, C; Canals, C; Goldstone, A; Caballero, D; Metzner, B; Kobbe, G; Kolb, H-J; ... Schmitz, N; + view all (2008) High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: Complete remission at transplantation is the major determinant of outcome - Lymphoma working party of the European group for blood and marrow transplantation. JOURNAL OF CLINICAL ONCOLOGY , 26 (2) pp. 218-224. 10.1200/JCO.2007.12.6219.

Kyriakou, C; Rabin, N; Pizzey, A; Nathwani, A; Yong, K; (2008) Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. HAEMATOL-HEMATOL J , 93 (10) 1457 - 1465. 10.3324/haematol.12553. Gold open access

Kyriakou, C; Rabin, N; Pizzey, A; Nathwani, A; Yong, K; (2008) Short term homing of human bone marrow derived mesenchymal stem cells (hMSCs) in a xenogeneic animal model is influenced by animal age and is increased by enforced expression of CXCR4. Haematologica , 93 (10) pp. 1457-1465. Gold open access

L

Lambert, JR; Austin, SK; Peebles, D; Cohen, H; (2008) Audit of the peri-delivery use of unfractionated heparin in women on therapeutic low-molecular weight heparin. BRIT J HAEMATOL , 142 (3) 453 - 456. 10.1111/j.1365-2141.2008.07198.x.

Lambert, JR; Bomanji, JB; Cooper, N; Hart, DP; Peggs, K; Thomson, K; Ell, PJ; (2008) Pre-Transplant PET Status May Not Impact on Survival Following Reduced-Intensity Allogeneic Stem-Cell Transplant for Lymphoma. However, Post-Transplant Surveillance with PET May Be Important for Directing Immunotherapy. In: BLOOD. (pp. 1118 - 1118). AMER SOC HEMATOLOGY

Lambert, JR; Gale, R; Linch, DC; (2008) The Relationship Between Wild Type and Mutant-Positive Platelets in Essential Thrombocythemia Patients with a JAK2 V617F Mutation. In: BLOOD. (pp. 1278 - 1278). AMER SOC HEMATOLOGY

Lawrie, AS; Cardigan, RA; Williamson, LM; Machin, SJ; Mackie, IJ; (2008) The dynamics of clot formation in fresh-frozen plasma. VOX SANG , 94 (4) 306 - 314. 10.1111/j.1423-0410.2008.01037.x.

Lawrie, AS; Harrison, P; Cardigan, RA; Mackie, IJ; (2008) The characterization and impact of microparticles on haemostasis within fresh-frozen plasma. VOX SANG , 95 (3) 197 - 204. 10.1111/j.1423-0410.2008.01081.x.

Lear, SE; Jamal, S; Lipman, M; Breen, R; Lowdell, M; (2008) Immunophenotyping of Alveolar FluidWe present a locally-developed procedure for routine use in the UK diagnostic laboratory. In: (Proceedings) 13th European-Soc-for-Immunodeficiencies/10th Int-Patient-Org-for-Primary-Immunodeficiencies/8th Int-Nursing-Group-for-Immunodeficiencies Meeting. (pp. pp. 172-173). WILEY-BLACKWELL PUBLISHING, INC

Lee, JW; Yoon, SS; Shen, ZX; Hsu, HC; Ganser, A; Habr, D; Domokos, G; ... Porter, JB; + view all (2008) Iron Chelation in Regularly Transfused Patients with Aplastic Anemia: Efficacy and Safety Results from the Large Deferasirox EPIC Trial. In: BLOOD. (pp. 167 - 168). AMER SOC HEMATOLOGY

Lee, L; Donaldson, A; Lok, S; (2008) A simple case of heart failure? Br J Hosp Med (Lond) , 69 (3) 167-. 10.12968/hmed.2008.69.3.28755.

Lorain, S; Gross, D-A; Goyenvalle, A; Danos, O; Davoust, J; Garcia, L; (2008) Transient immunomodulation allows repeated injections of AAV1 and correction of muscular dystrophy in multiple muscles. Mol Ther , 16 (3) pp. 541-547. 10.1038/sj.mt.6300377.

M

Mackie, IJ; Eapen, CE; Desley, N; Elias, E; (2008) Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension Is Associated with Sustained ADAMTS13 Deficiency. In: BLOOD. (pp. 801 - 801). AMER SOC HEMATOLOGY

Mackinnon, S; Morris, EC; Bloor, A; Cook, G; Milligan, D; Parker, A; Craddock, C; ... Thomson, KJ; + view all (2008) Excellent long-term survival following reduced intensity allogeneic transplantation for multiply relapsed follicular lymphoma. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 119 - 119). BLACKWELL PUBLISHING

Mackinnon, S; Morris, EC; Bloor, A; Cook, G; Milligan, D; Parker, A; Craddock, C; ... Thomson, KJ; + view all (2008) Favourable long-term survival following reduced intensity allogeneic transplantation for multiply relapsed aggressive non-Hodgkins lymphoma. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 121 - 121). BLACKWELL PUBLISHING

Mackinnon, S; Thomson, K; Verfuerth, S; Peggs, K; Lowdell, M; (2008) Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells. BLOOD CELLS MOLECULES AND DISEASES , 40 (1) 63 - 67. 10.1016/j.bcmd.2007.07.003.

Madrigal, A; Shaw, BE; (2008) Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation. BLOOD CELLS MOLECULES AND DISEASES , 40 (1) 40 - 43. 10.1016/j.bcmd.2007.08.004.

Malanchi, I; Peinado, H; Kassen, D; Hussenet, T; Metzger, D; Chambon, P; Huber, M; ... Huelsken, J; + view all (2008) Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. NATURE , 452 (7187) 650 - U12. 10.1038/nature06835.

Mannari, D; Liu, C; Hughes, D; Mehta, A; (2008) The role of heparin in alleviating complement-mediated acute intravascular haemolysis. ACTA HAEMATOLOGICA , 119 (3) pp. 166-168. 10.1159/000134221.

Mansour, MR; Gale, R; Khwaja, A; Pule, M; Hills, R; Burnett, AK; Linch, D; (2008) CSL-TREX: A Novel Alternatively Spliced Isoform of CSL (RBPJ-K) Predominates Over the Full-Length Isoform in Many Patients with Acute Myeloid Leukaemia, Can Activate Notch Signalling and Is Associated with Improved Outcome. In: BLOOD. (pp. 1155 - 1155). AMER SOC HEMATOLOGY

Mansour, MR; Sulis, ML; Duke, V; Foroni, L; Jenkinson, S; Allen, CG; Gale, RE; ... Linch, DC; + view all (2008) Unlike Paediatric T-ALL, Notch-1 and FBXW7 Mutations Do Not Seem to Predict a Better Outcome in Adult Patients: Data from the UKALLXII/ECOG2993 Protocol. In: BLOOD. (pp. 885 - 885). AMER SOC HEMATOLOGY

Marsh, SGE; (2008) Nomenclature for Factors of the HLA System, Update December 2007. HUMAN IMMUNOLOGY , 69 (2) pp. 139-140. 10.1016/j.humimm.2008.01.001.

Marsh, SGE; (2008) Nomenclature for Factors of the HLA System, update June 2008. HUMAN IMMUNOLOGY , 69 (9) pp. 588-590. 10.1016/j.humimm.2008.07.002.

Marsh, SGE; (2008) Nomenclature for factors of the HLA system, update April 2008. HUMAN IMMUNOLOGY , 69 (8) pp. 526-528. 10.1016/j.humimm.2008.06.011.

Marsh, SGE; (2008) Nomenclature for factors of the HLA system, update April 2008. TISSUE ANTIGENS , 72 (3) pp. 221-223. 10.1111/j.1399-0039.2008.01104.x.

Marsh, SGE; (2008) Nomenclature for factors of the HLA system, update December 2007. TISSUE ANTIGENS , 71 (3) pp. 262-263. 10.1111/j.1399-0039.2007.01004.x.

Marsh, SGE; (2008) Nomenclature for factors of the HLA system, update February 2008. TISSUE ANTIGENS , 71 (6) pp. 582-584. 10.1111/j.1399-0039.2008.01054.x.

Marsh, SGE; (2008) Nomenclature for factors of the HLA system, update January 2008. TISSUE ANTIGENS , 71 (6) pp. 580-581. 10.1111/j.1399-0039.2008.01053.x.

Marsh, SGE; (2008) Nomenclature for factors of the HLA system, update June 2008. TISSUE ANTIGENS , 72 (4) pp. 412-413. 10.1111/j.1399-0039.2008.01109.x.

Marsh, SGE; (2008) Nomenclature for factors of the HLA system, update March 2008. TISSUE ANTIGENS , 72 (1) pp. 84-86. 10.1111/j.1399-0039.2008.01055.x.

Marsh, SGE; (2008) Nomenclature for factors of the HLA system, update May 2008. TISSUE ANTIGENS , 72 (3) pp. 224-226. 10.1111/j.1399-0039.2008.01105.x.

Marsh, SGE; (2008) Nomenclature for factors of the HLA system, update November 2007. TISSUE ANTIGENS , 71 (3) pp. 260-261. 10.1111/j.1399-0039.2007.00996.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2008) Nomenclature for factors of the HLA system, update October 2007. Tissue Antigens , 71 (2) pp. 183-184. 10.1111/j.1399-0039.2007.00994.x.

Mattes, FM; Vargas, A; Kopycinski, J; Hainsworth, EG; Sweny, P; Nebbia, G; Bazeos, A; ... Emery, VC; + view all (2008) Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. AM J TRANSPLANT , 8 (5) 990 - 999. 10.1111/j.1600-6143.2008.02191.x.

Mayor, NP; Shaw, BE; Hughes, DA; Maldonado-Torres, H; Madrigal, JA; Keshav, S; Marsh, SGE; (2008) In reply [6]. Journal of Clinical Oncology , 26 (2) 339-. 10.1200/JCO.2007.14.3123.

Mayor, NP; Shaw, BE; Hughes, DA; Maldonado-Torres, H; Madrigal, JA; Keshav, S; Marsh, SGE; (2008) NOD2/CARD15 polymorphisms in allogeneic stem-cell transplantation from unrelated donors: T depletion matters - Reply. J CLIN ONCOL , 26 (2) 339 - 339. 10.1200/JCO.2007.14.3123.

Mayor, NP; Shaw, BE; Madrigal, JA; Marsh, SGE; (2008) No impact of NOD2/CARD15 on outcome after SCT: a reply. BONE MARROW TRANSPL , 42 (12) 837 - 838. 10.1038/bmt.2008.251.

Mayor, NP; Shaw, BE; Madrigal, JA; Marsh, SGE; (2008) Prediction of disease relapse using HLA-DPB1 matching and NOD2/CARD15 genotype in unrelated donor haematopoietic stem cell transplant for acute leukaemia. In: TISSUE ANTIGENS. (pp. 282 - 282). BLACKWELL PUBLISHING

Mayor, NP; Shaw, BE; Marsh, SGE; Madrigal, JA; (2008) Predicting disease relapse using HLA-DPB1 matching status and NOD2/CARD15 genotype in recipients of an unrelated donor haematopoietic stem cell transplant for acute leukaemia. In: BONE MARROW TRANSPLANTATION. (pp. S73 - S74). NATURE PUBLISHING GROUP

McDonald, V; Scully, M; Mackie, IJ; Manns, K; Machin, SJ; (2008) The Effect of Plasma Exchange on Rituximab Levels and Response to Rituximabin Patients with Acute Idiopathic Thrombotic Thrombocytopenic Pupura (TTP). In: BLOOD. (pp. 801 - 801). AMER SOC HEMATOLOGY

Mead, AJ; Gale, RE; Hills, RK; Gupta, M; Young, BD; Burnett, AK; Linch, DC; (2008) Conflicting data on the prognostic significance of FLT3/TKD mutations in acute myeloid leukemia might be related to the incidence of biallelic disease. BLOOD , 112 (2) 444 - 445.

Mead, AJ; Gale, RE; Kottaridis, PD; Matsuda, S; Khwaja, A; Linch, DC; (2008) Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication. British Journal of Haematology , 141 (4) pp. 454-460. 10.1111/j.1365-2141.2008.07025.x.

Mead, AJ; Gale, RE; Kottaridis, PD; Matsuda, S; Khwaja, A; Linch, DC; (2008) Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication. BRIT J HAEMATOL , 141 (4) 454 - 460. 10.1111/j.1365-2141.2008.07025.x.

Mead, AJ; Khwaja, A; Gale, R; Linch, DC; (2008) FLT3 ITD and TKD Mutations Differ in Their Functional Consequence in Both Cell Line Models and Primary Hematopoietic Cells. In: BLOOD. (pp. 1297 - 1297). AMER SOC HEMATOLOGY

Mead, AJ; Thomson, KJ; Morris, EC; Chakraverty, R; Linch, DC; Mackinnon, S; Peggs, KS; (2008) Mismatch at 1-2 HLA Loci Does Not Reduce Survival Following Alemtuzumab-Based Reduced Intensity Unrelated Donor Allogeneic Transplantation. In: BLOOD. (pp. 1035 - 1035). AMER SOC HEMATOLOGY

Mehta, A; (2008) Fabry disease: Whom to treat and when. Clinical Therapeutics , 30

Mehta, A; (2008) Gaucher disease: unmet treatment needs. Acta Paediatrica - Supplement , 97 (457) pp. 83-87.

Mehta, AB; (2008) Glucose-6 phosphate-deficiency. BMJ point of care

Mehta, AB; Beck, M; Frustaci, A; Germain, D; Pastores, G; Sunder-Plassmann, ; (2008) Enzyme replacement therapy in Fabry disease: Comparison of agalsidase alfa and agalsidase beta. Molecular Genetics and Metabolism , 95 (114) 115-.

Mehta, APR; (2008) Fabry disease: beyond men. Acta Paediatrica - Supplement , 97 (457) pp. 31-32.

Meja, KK; Rajendrasozhan, S; Adenuga, D; Biswas, SK; Sundar, IK; Spooner, G; Marwick, JA; ... Rahman, I; + view all (2008) Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am J Respir Cell Mol Biol , 39 (3) pp. 312-323. 10.1165/rcmb.2008-0012OC.

Middleton, D; Gonzalez, F; Marsh, SGE; (2008) A BIOINFORMATIC APPROACH TO ASCERTAINING THE RARITY OF HLA ALLELES. In: (Proceedings) 34th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. S1-S1). ELSEVIER SCIENCE INC

Mikosch, P; Kohlfuerst, S; Gallowitsch, HJ; Kresnik, E; Lind, P; Mehta, AB; Hughes, DA; (2008) Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature. NUKLEARMEDIZIN-NUCLEAR MEDICINE , 47 (6) pp. 239-247. 10.3413/nukmed-0142.

Mikosch, P; Kohlfürst, S; Gallowitsch, HJ; Kresnik, E; Lind, P; Mehta, AB; Hughes, DA; (2008) Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature. Nuklearmedizin , 47 (6) pp. 239-247.

Mikosch, P; Reed, M; Baker, R; Holloway, B; Berger, L; Mehta, AB; Hughes, DA; (2008) Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat. CALCIFIED TISSUE INT , 83 (1) 43 - 54. 10.1007/s00223-008-9143-4.

Mikosch, P; Reed, M; Baker, R; Holloway, B; Berger, L; Mehta, AB; Hughes, DA; (2008) Changes of bone metabolism in seven patients with gaucher disease treated consecutively with imiglucerase and miglustat. Calcified Tissue International , 83 (1) pp. 43-54. 10.1007/s00223-008-9143-4.

Mikosch, P; Zitter, F; Gallowitsch, HJ; Wurtz, F; Lind, P; Mehta, AB; Hughes, DA; (2008) Bone- and bone marrow scintigraphy in Gaucher disease type 1. NUKLEARMED-NUCL MED , 47 (4) N39 - N43.

Mikosch, P; Zitter, F; Gallowitsch, HJ; Würtz, F; Lind, P; Mehta, AB; Hughes, DA; (2008) Bone- and bone marrow scintigraphy in Gaucher disease type 1. Nuklearmedizin. Nuclear medicine , 47 (4)

Millar, CM; Riddell, AF; Brown, SA; Starke, R; Mackie, I; Bowen, DJ; Jenkins, PV; (2008) Survival of von Willebrand factor released following DDAVP in a type I von Willebrand disease cohort: Influence of glycosylation, proteolysis and gene mutations. THROMB HAEMOSTASIS , 99 (5) 916 - 924. 10.1160/TH07-09-0565.

Millar, CM; Riddell, AF; Tuddenham, EG; (2008) Consideration of platelet function disorders in patients with reduced VWF levels. HAEMOPHILIA , 14 (5) pp. 1131-1132. 10.1111/j.1365-2516.2008.01818.x.

Milligan, A; Bruce, R; Freud, C; Goodwin, S; Hughes, DA; Jennings, A; Richfield, L; ... Mehta, A; + view all (2008) Compliance with home treatment using enzyme replacement therapy for type 1 Gaucher disease: a UK centre perspective. ACTA PAEDIATR , 97 114 - 114.

Mohamedbhai, S; Pule, M; Conn, B; Hopper, C; Ramsay, A; Khwaja, A; (2008) Acute promyelocytic leukaemia presenting with a myeloid sarcoma of the tongue. Br J Haematol , 141 (5) 565-. 10.1111/j.1365-2141.2008.07080.x.

N

Natkunarajah, M; Trittibach, P; McIntosh, J; Duran, Y; Barker, SE; Smith, AJ; Nathwani, AC; (2008) Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8. GENE THER , 15 (6) 463 - 467. 10.1038/sj.gt.3303074.

O

Orti, G; Peggs, K; Thomson, K; Morris, E; Lowdell, M; Mackinnon, S; Chakraverty, R; (2008) Phase I Study of Transfer of CD8 Depleted Donor Leukocytes after Allogencic Stem Cell Transplantation. In: BLOOD. (pp. 768 - 769). AMER SOC HEMATOLOGY

Ounjaijean, S; Thephinlap, C; Khansuwan, U; Phisalapong, C; Fucharoen, S; Porter, JB; Srichairatanakool, S; (2008) Effect of green tea on iron status and oxidative stress in iron-loaded rats. MED CHEM , 4 (4) 365 - 370.

P

Panjideh, H; Da Silva Coelho, VC; Dernedde, J; Bachran, C; Förster, GJ; Franke, J; Fasold, P; ... Deckert, PM; + view all (2008) Biodistribution and efficacy of [131I]A33scFv::CDy, a recombinant antibody-enzyme protein for colon cancer. Int J Oncol , 32 (4) pp. 925-930.

Patel, B; Richards, SM; Rowe, JM; Goldstone, AH; Fielding, AK; (2008) High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis. LEUKEMIA , 22 (2) 308 - 312. 10.1038/sj.leu.2405032.

Patel, C; Hughes, D; Jennings, A; Jeevaratnam, P; Milligan, A; Pringle, S; Richfield, L; (2008) THE INCREASED AWARENESS OF ANDERSON-FABRY DISEASE AMONG PATIENTS CHANGING REFERRAL PATTERNS. Presented at: 5th Symposium on Lysosomal Storage Disorders, Paris, FRANCE.

Payne, EMC; (2008) The molecular basis of cancer. In: Mendelsohn, J, (ed.) The molecular basis of cancer. W B Saunders Co

Peggs, KS; Anderlini, P; Sureda, A; (2008) Allogeneic transplantation for Hodgkin lymphoma. BRIT J HAEMATOL , 143 (4) 468 - 480. 10.1111/j.1365-2141.2008.07349.x.

Peggs, KS; Quezada, SA; Allison, JP; (2008) Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy. IMMUNOL REV , 224 141 - 165.

Peggs, KS; Quezada, SA; Allison, JP; (2008) Checkpoint blockade and combinatorial immunotherapies. In: General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology. (pp. 363-390).

Peggs, KS; Verfuerth, S; Pizzey, A; Chow, C; Thomson, K; Mackinnon, S; (2008) CMV-Specific T cell Immunotherapy Promotes Restoration of Durable Functional Immunity in High Risk Patients Following Allogeneic Stem Cell Transplantation. In: BLOOD. (pp. 137 - 138). AMER SOC HEMATOLOGY

Pennell, D; Porter, JB; Cappellini, MD; Li, CK; Aydinok, Y; Lee, CL; Kattamis, A; ... Taher, A; + view all (2008) Efficacy and Safety of Deferasirox (Exjade (R)) in Reducing Cardiac Iron in Patients with beta-Thalassemia Major: Results from the Cardiac Substudy of the EPIC Trial. In: BLOOD. (pp. 1318 - 1318). AMER SOC HEMATOLOGY

Pennell, D; Sutcharitchan, P; El-Beshlawy, A; Aydinok, Y; Taher, A; Smith, G; Habr, D; ... Porter, JB; + view all (2008) Efficacy and Safety of Deferasirox (Exjade (R)) in Preventing Cardiac Iron Overload in beta-Thalassemia Patients with Normal Baseline Cardiac Iron: Results from the Cardiac Substudy of the EPIC Trial. In: BLOOD. (pp. 1318 - 1319). AMER SOC HEMATOLOGY

Perera, R; Heneghan, C; Fitzmaurice, D; Self, MTSMT; (2008) Individual patient meta-analysis of self-monitoring of an oral anticoagulation protocol. The Journal of heart valve disease , 17 (2) p. 233.

Popat, R; Maharaj, L; Oakervee, H; Cavenagh, J; Middleton, B; Rioja, A; Marson, C; (2008) THE NOVEL HDAC INHIBITOR UCL67022 HAS POTENT ACTIVITY IN MULTIPLE MYELOMA CELLS AND REMAINS EFFECTIVE IN A BONE MARROW MICRO-ENVIRONMENT MODEL. In: (Proceedings) 13th Congress of the European-Hematology-Association. (pp. p. 115). FERRATA STORTI FOUNDATION Gold open access

Popat, R; Oakervee, H; Williams, C; Cook, M; Craddock, C; Basu, S; Singer, C; ... Cavenagh, J; + view all (2008) BORTEZOMIB, LOW DOSE INTRAVENOUS MELPHALAN AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED MULTIPLE MYELOMA. In: (Proceedings) 13th Congress of the European-Hematology-Association. (pp. pp. 365-366). FERRATA STORTI FOUNDATION Gold open access

Popat, R; Oakervee, HE; Hallam, S; Curry, N; Odeh, L; Foot, N; Esseltine, D-L; ... Cavenagh, JD; + view all (2008) Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up. BRITISH JOURNAL OF HAEMATOLOGY , 141 (4) pp. 512-516. 10.1111/j.1365-2141.2008.06997.x.

Popat, R; Williams, C; Cook, M; Craddock, C; Basu, S; Singer, C; Odeh, L; ... Cavenagh, J; + view all (2008) Bortezomib, low dose iv melphalan and dexamethasone for patients with relapsed multiple myeloma. In: (Proceedings) 48th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 120). BLACKWELL PUBLISHING

Porter, J; Galanello, R; Saglio, G; Neufeld, EJ; Vichinsky, E; Cappellini, MD; Olivieri, N; ... Rose, C; + view all (2008) Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. EUR J HAEMATOL , 80 (2) 168 - 176. 10.1111/j.1600-0609.2007.00985.x.

Porter, JB; Bowden, D; Ganser, A; Domokos, G; Gater, A; Baladi, JF; Cappellini, MD; (2008) Improved Health-Related Quality of Life in Patients with Hematological Disorders Receiving Deferasirox (Exjade (R)). In: BLOOD. (pp. 473 - 473). AMER SOC HEMATOLOGY

Porter, JB; Bowden, D; Ganser, A; Domokos, G; Rofail, D; Baladi, JF; Cappellini, MD; (2008) Satisfaction and Adherence Significantly Improves in Patients with beta-Thalassemia and Myelodysplastic Syndromes Treated with Deferasirox. In: BLOOD. (pp. 472 - 472). AMER SOC HEMATOLOGY

Porter, JB; Cappellini, MD; El-Beshlawy, A; Kattamis, A; Seymour, JF; Lee, JW; Nick, H; ... Taher, A; + view all (2008) Effect of Deferasirox (Exjade (R)) on Labile Plasma Iron Levels in Heavily Iron-Overloaded Patients with Transfusion-Dependent Anemias Enrolled in the Large-Scale, Prospective 1-Year EPIC Trial. In: BLOOD. (pp. 1322 - 1322). AMER SOC HEMATOLOGY

Porter, JB; Forni, GL; Beris, P; Taher, A; Habr, D; Domokos, G; Hmissi, A; (2008) Efficacy and Safety of 1 Year's Treatment with Deferasirox (Exjade (R)): Assessment of Regularly Transfused Patients with Diamond-Blackfan Anemia Enrolled in the EPIC Study. In: BLOOD. (pp. 384 - 384). AMER SOC HEMATOLOGY

Porter, JB; Lin, KH; Habr, D; Domokos, G; Hmissi, A; Thein, SL; (2008) Deferasirox Efficacy and Safety for the Treatment of Transfusion-Dependent Iron Overload in Patients with a Range of Rare Anemias. In: BLOOD. (pp. 506 - 506). AMER SOC HEMATOLOGY

Porter, JB; Taher, AT; Cappellini, MD; Vichinsky, EP; (2008) Ethical Issues and Risk/Benefit Assessment of Iron Chelation Therapy: Advances with Deferiprone/deferoxamine Combinations and Concerns about the Safety, Efficacy and Costs of Deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.]. HEMOGLOBIN , 32 (6) 601 - 607. 10.1080/03630260802342008.

Prieto-Hinojosa, A; Madrigal, A; Shaw, BE; Mayor, NP; Maldonado-Torres, H; Marsh, SEG; Travers, PJ; (2008) Association of cytokine levels in unrelated haematopoietic stem cell transplantation outcome. In: BONE MARROW TRANSPLANTATION. (pp. S326 - S326). NATURE PUBLISHING GROUP

Pringle, S; Bruce, R; Goodwin, S; Hughes, D; Jennings, A; Jeevaratnam, P; Milligan, A; ... Mehta, A; + view all (2008) SUCCESSFUL MANAGEMENT OF A YOUNG MALE WITH TYPE 3 GAUCHER DISEASE: A CASE PRESENTATION. Presented at: 5th Symposium on Lysosomal Storage Disorders, Paris, FRANCE.

Pringle, S; Hughes, DA; Bruce, R; Goodwin, S; Jennings, A; Milligan, A; Richfield, L; ... Mehta, AB; + view all (2008) Successful management of a young male with a severe phenotype associated with glucocerebrosidase (GBA) deficiency: a case presentation. ACTA PAEDIATR , 97 116 - 117.

Q

Quezada, SA; Peggs, KS; Simpson, TR; Shen, YL; Littman, DR; Allison, JP; (2008) Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma. J EXP MED , 205 (9) 2125 - 2138. 10.1084/jem.20080099.

Quinn, J; Brooks, R; Peebles, D; Walker, F; Cohen, H; (2008) Dose-escalated low molecular weight heparin provides effective anticoagulation for women with mechanical heart valves during pregnancy: a single-centre experience. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 80 - 80). BLACKWELL PUBLISHING

Quinn, J; Mohamedbhai, S; Treacy, M; D'Sa, S; Nathwani, A; (2008) Rituximab in combination with high-dose steroids: a safe and effective salvage regimen in advanced, refractory chronic lymphocytic leukaemia. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 37 - 37). BLACKWELL PUBLISHING

Quinn, JP; Mohamedbhai, S; Chipperfield, K; Treacy, M; D'Sa, S; Nathwani, AC; (2008) Efficacy of rituximab in combination with steroids in refractory chronic lymphocytic leukemia. LEUKEMIA LYMPHOMA , 49 (10) 1995 - 1998. 10.1080/10428190802340192.

R

Reading, JL; Alvarez, R; King, DF; Hayes, M; Easterbrook, P; Farzaneh, F; Yang, F; ... Vyakarnam, A; + view all (2008) WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection. Journal of Virology

Richfield, L; Goodwin, S; Milligan, A; Hughes, DA; Jeevaratnam, P; Pringle, S; Bruce, R; (2008) Watchful waiting: the rationale for not treating some patients diagnosed with a lysosomal storage disorder. ACTA PAEDIATR , 97 119 - 120.

Roberts, CH; Shaw, BE; Mayor, NP; Madrigal, JA; Marsh, SGE; (2008) The impact of KIR gene and KIR ligand matching on the outcome of HSCT in the transplant population of the UK. In: TISSUE ANTIGENS. (pp. 281 - 282). BLACKWELL PUBLISHING

Robinson, J; Fail, SC; Waller, MJ; Stoehr, P; Parham, P; Marsh, SGE; (2008) 10 YEARS OF THE IMGT/HLA DATABASE. In: (Proceedings) 34th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. S102-S102). ELSEVIER SCIENCE INC

Robinson, SP; Sureda, A; Canals, C; Vernant, JP; Milpied, NJ; Finke, J; Maertens, J; ... Schmitz, N; + view all (2008) Identification of Prognostic Factors Predicting the Outcome of Reduced Intensity Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma. An Analysis from the Lymphoma Working Party of the EBMT. In: BLOOD. (pp. 174 - 175). AMER SOC HEMATOLOGY

Rosati, SF; Williams, RF; Nunnally, LC; McGee, MC; Sims, TL; Tracey, L; Zhou, J; ... Davidoff, AM; + view all (2008) IFN-β sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O<sup>6</sup>-methylguanine DNA methyltransferase expression. Molecular Cancer Therapeutics , 7 (12) pp. 3852-3858. 10.1158/1535-7163.MCT-08-0806.

Rosati, SF; Williams, RF; Nunnally, LC; McGee, MC; Sims, TL; Tracey, L; Zhou, JF; ... Davidoff, AM; + view all (2008) IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O-6-methylguanine DNA methyltransferase expression. MOL CANCER THER , 7 (12) 3852 - 3858. 10.1158/1535-7163.MCT-08-0806.

Rowe, JM; Buck, G; Moorman, AV; Tallman, MS; Richards, SM; Fielding, AK; Burnett, AK; ... Goldstone, AH; + view all (2008) Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993). BLOOD , 112 (11) p. 1138.

Ryland, JK; Lawrie, AS; Machin, SJ; Mackie, IJ; (2008) Thrombin generation: the effect of pre-analytical variables on the calibrated automated thrombograrn. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 79 - 79). BLACKWELL PUBLISHING

S

Sarantos, K; Evans, P; Garbowski, M; Davis, B; Porter, JB; (2008) Vitamin C Deficiency in Patients on Long-Term Deferasirox without Supplementation. In: BLOOD. (pp. 652 - 653). AMER SOC HEMATOLOGY

Scully, M; Briggs, C; Mcdonald, V; Longair, I; Mackie, I; Machin, S; (2008) ADAMTS 13 levels in acute TTP: role in diagnosis, monitoring of treatment and relapse. INT J LAB HEMATOL , 30 21 - 21.

Scully, M; Yarranton, H; Liesner, R; Cavenagh, J; Hunt, B; Benjamin, S; Bevan, D; ... Machin, S; + view all (2008) Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features. BRIT J HAEMATOL , 142 (5) 819 - 826. 10.1111/j.1365-2141.2008.07276.x.

Segal, NH; Parsons, DW; Peggs, KS; Velcutlescu, V; Kinzler, KW; Vogelstein, B; Allison, JP; (2008) Epitope landscape in breast and colorectal cancer. CANCER RES , 68 (3) 889 - 892. 10.1158/0008-5472.CAN-07-3095.

Senzolo, M; Riddell, A; Tuddenham, E; Burroughs, AK; (2008) Endogenous heparinoids contribute to coagulopathy in patients with liver disease. J Hepatol , 48 (2) pp. 371-372. 10.1016/j.jhep.2007.11.003.

Shaw, B; Russell, N; Pagliuca, A; Apperley, J; Cook, G; Mackinnon, S; Madrigal, J; ... Study ANT & BSBMT, ; + view all (2008) No impact on survival is seen when comparing the use of BM or PBSC as the stem cell source in recipients of T-cell depleted myeloablative transplants for leukaemia and MDS. In: BONE MARROW TRANSPLANTATION. (pp. S146 - S146). NATURE PUBLISHING GROUP

Shaw, BE; (2008) The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation. INT J IMMUNOGENET , 35 (4-5) 367 - 374. 10.1111/j.1744-313X.2008.00793.x.

Shaw, BE; Mufti, GJ; Mackinnon, S; Cavenagh, JD; Pearce, RM; Towlson, KE; Apperley, JF; ... Russell, NH; + view all (2008) Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. BONE MARROW TRANSPL , 42 (12) 783 - 789. 10.1038/bmt.2008.255.

Shaw, BE; Russell, NH; (2008) Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant. BONE MARROW TRANSPL , 41 (5) 495 - 503. 10.1038/sj.bmt.1705888.

Srikanth, M; Davies, FE; Wu, P; Jenner, MW; Ethell, ME; Potter, MN; Shaw, BE; ... Morgan, GJ; + view all (2008) Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT-PACE. EUR J HAEMATOL , 81 (6) 432 - 436. 10.1111/j.1600-0609.2008.01131.x.

Stainsby, D; Jones, H; Wells, AW; Gibson, B; Cohen, H; SHOT Steering Grp, ; (2008) Adverse outcomes of blood transfusion in children: analysis of UK reports to the serious hazards of transfusion scheme 1996-2005. BRIT J HAEMATOL , 141 (1) 73 - 79. 10.1111/j.1365-2141.2008.07022.x.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Nacheva, EP; Howard-Reeves, JD; ... Wickremasinghe, RG; + view all (2008) p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism. BLOOD , 112 (9) 3827 - 3834. 10.1182/blood-2008-05-156380.

T

Takeuchi, Y; Myers, R; Danos, O; (2008) Recombination and Population Mosaic of a Multifunctional Viral Gene, Adeno-Associated Virus cap. PLOS ONE , 3 (2) , Article e1634. 10.1371/journal.pone.0001634. Green open access
file

Tanner, MA; Galanello, R; Dessi, C; Smith, GC; Westwood, MA; Agus, A; Pibiri, M; ... Pennell, DJ; + view all (2008) Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE , 10 (ARTN 12) 10.1186/1532-429X-10-12.

Tappenden, KA; Gallimore, MJ; Evans, G; Mackie, IJ; Jones, DW; (2008) Thrombin generation in whole blood - response to Al Dieri & Hemker. BRIT J HAEMATOL , 141 (6) 896 - 897. 10.1111/j.1365-2141.2008.07110.x.

Taylor, C; Cohen, H; Jones, H; (2008) The 2007 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Tholouli, E; Liakopoulou, E; Greenfield, HM; Shaw, BE; Tauro, S; Byrne, JL; Dennis, M; ... Yin, JAL; + view all (2008) Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia. BRIT J HAEMATOL , 142 (2) 318 - 320. 10.1111/j.1365-2141.2008.07184.x.

Thomson, KJ; Peggs, KS; Smith, P; Cavet, J; Hunter, A; Parker, A; Pettengell, R; ... Mackinnon, S; + view all (2008) Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation. Bone Marrow Transplantation , 41 (9) pp. 765-770. 10.1038/sj.bmt.1705977.

Thomson, KJ; Peggs, KS; Smith, P; Cavet, J; Hunter, A; Parker, A; Pettengell, R; ... Mackinnon, S; + view all (2008) Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation. BONE MARROW TRANSPL , 41 (9) 765 - 770. 10.1038/sj.bmt.1705977.

Trung, DT; Hien, TT; Thao, LTT; Dung, NM; Van Ngoc, T; Goldin, R; Tuddenham, E; ... Wills, B; + view all (2008) PATHOGENESIS OF HAEMORRHAGE ASSOCIATED WITH DENGUE INFECTION IN ADULTS IN VIETNAM. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE , 79 (6) p. 360.

Tuddenham, EG; Ingerslev, J; Sorensen, LN; Christiansen, K; Mariani, G; Peyvandi, F; Waddington, SN; ... Berntorp, E; + view all (2008) Genetic aspects and research development in haemostasis. HAEMOPHILIA , 14 113 - 118.

V

Velica, P; Bunce, CM; (2008) Prostaglandins in muscle regeneration. J MUSCLE RES CELL M , 29 (6-8) 163 - 167. 10.1007/s10974-008-9154-9.

Veraitch, FS; Hemsley, AH; Scott, R; Wong, JW; Hernandez, D; Lye, GJ; Mason, C; ... Pelling, AE; + view all (2008) The response of embryonic stem cells to extra-cellular forces. In: (Proceedings) Annual meeting of the International Society for Stem Cell Research. : Philadelphia, US.

Verfuerth, S; Peggs, KS; Pizzey, A; Chowdhry, N; Mackinnon, S; (2008) Cytomegalovirus (CMV)-Specific CD8+T Cells Are Associated with Control of Viral Reactivation Post-Hemopoietic Stem Cell Transplantation (HSCT) Only If Shown to Be Functionally Active. In: BLOOD. (pp. 772 - 772). AMER SOC HEMATOLOGY

Vichinsky, E; Pakbaz, Z; Onyekwere, O; Porter, J; Swerdlow, P; Coates, T; Lane, P; ... Baladi, JF; + view all (2008) Patient-reported outcomes of deferasirox (Exjade (R), ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. ACTA HAEMATOL-BASEL , 119 (3) 133 - 141. 10.1159/000125550.

Virappane, P; Gale, R; Hills, R; Kakkas, I; Summers, K; Stevens, J; Allen, C; ... Fitzgibbon, J; + view all (2008) Mutation of the Wilms' Tumor 1 Gene Is a Poor Prognostic Factor Associated With Chemotherapy Resistance in Normal Karyotype Acute Myeloid Leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 5429 - 5435). AMER SOC CLINICAL ONCOLOGY

W

Walter, PB; Macklin, EA; Porter, J; Evans, P; Kwiatkowski, JL; Neufeld, EJ; Coates, T; ... Thalassemia Clinical Res Network, ; + view all (2008) Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. HAEMATOL-HEMATOL J , 93 (6) 817 - 825. 10.3324/haematol.11755. Gold open access

Walter, PB; Porter, JB; Evans, P; Kwiatkowski, J; Neufeld, EJ; Coates, TD; Giardina, P; ... Harmatz, P; + view all (2008) Increased Nucleosomal DNA Fragmentation in Leukocytes of Thalassemia Patients. In: BLOOD. (pp. 655 - 655). AMER SOC HEMATOLOGY

Ward, NJ; Apolonia, L; Fernandes, C; Waddington, SN; Cochrane, M; Nathwani, AC; Thrasher, AJ; ... Philpott, NJ; + view all (2008) Non-integrating lentiviral vector pseudotypes for safer gene therapy. In: HUMAN GENE THERAPY. (pp. 419 - 419). MARY ANN LIEBERT INC

Westerman, M; Pizzey, A; Hirschman, J; Cerino, M; Weil-Weiner, Y; Ramotar, P; Eze, A; ... Porter, J; + view all (2008) Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. BRIT J HAEMATOL , 142 (1) 126 - 135. 10.1111/j.1365-2141.2008.07155.x.

Work, LM; Baker, AH; Graham, T; McIntosh, J; Nathwani, A; (2008) Performance of AAV8 vectors expressing human factor IX from a hepatic-selective promoter following intravenous injection into rats. Genetic Vaccines and Therapy , 6 , Article 9. 10.1186/1479-0556-6-9. Green open access
file

Y

Yan, MY; Himoudi, N; Pule, M; Sebire, N; Poon, E; Blair, A; Williams, O; (2008) Development of cellular immune responses against PAX5, a novel target for cancer immunotherapy. CANCER RES , 68 (19) 8058 - 8065. 10.1158/0008-5472.CAN-08-0153.

Yee, T; Maimone, S; Calvaruso, V; Griffioen, A; Lilley, P; Patch, D; (2008) Fibroscan in a cohort of individuals with an inherited bleeding disorder and active chronic hepatitis C virus infection. HAEMOPHILIA , 14 41 - 41.

Z

Zhang, B; Spreafico, M; Zheng, C; Yang, A; Platzer, P; Callaghan, MU; Avci, Z; ... Ginsburg, D; + view all (2008) Genotype-phenotype correlation in combined deficiency of factor V and factor VIII. Blood , 111 (12) pp. 5592-5600. 10.1182/blood-2007-10-113951.

Zimran, A; Belmatoug, N; Granovosky-Grisaru, S; Heitner, R; Hughes, DA; Kaplan, P; Malinova, V; ... vom Dahl, S; + view all (2008) MANAGEMENT OF REPRODUCTIVE EVENTS IN FEMALES WITH GAUCHER DISEASE. Presented at: 13th Congress of the European-Hematology-Association, Copenhagen, DENMARK.

This list was generated on Sun Aug 18 05:04:01 2019 BST.